Latest Soft tissue sarcoma Stories
SAN MARINO, Calif., June 1 /PRNewswire/ -- Epeius Biotechnologies Corporation (www.epeiusbiotech.com) today announces the results of the clinical trial entitled "Advanced Phase I/II Evaluation of Tumor-Targeted Gene Delivery: Intravenous Rexin-G as Stand Alone Therapy for Chemotherapy-resistant Bone and Soft Tissue Sarcoma" at the ASCO Annual Meeting on June 8, 2010.
SEATTLE, May 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
NEW YORK, April 21 /PRNewswire/ -- The Kristen Ann Carr Fund has awarded a grant to Jonathan Lewis, MD, PhD, Chief Executive Officer and Chief Medical Officer of ZIOPHARM Oncology, Inc., which will fund translational work at the Memorial Sloan-Kettering Cancer Center and the Albert Einstein College of Medicine in New York City, for the development of a novel treatment for pediatric sarcoma.
MADRID, March 15 /PRNewswire/ -- Centocor Ortho Biotech Products has informed PharmaMar SA (Grupo Zeltia, ZEL.MC) that the regulatory authorities in Israel, Panama and Ukraine have approved Yondelis(R) for advanced soft tissue sarcoma (STS) in adults.
New breakthrough treatments for the most common cancers could soon come from cutting-edge research into some of the world's rarest tumors.
Benefit is not proven â€“ use can only be justified within controlled clinical trials at present.
CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
CALGARY, Oct. 30 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
Researchers at UCLA's Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called neurofibromas into a malignant and extremely deadly form of sarcoma.
Parkinson's Disease, Two Other Illnesses Recognized WASHINGTON, Oct. 13 /PRNewswire-USNewswire/ -- Relying on an independent study by the Institute of Medicine (IOM), Secretary of Veterans Affairs Eric K.
- A mania for the use of printing-types; a strong propensity to write for publication.